Clinical Trial: Clinical Study of Central Radiofrequency Ablation (SCART) Combined with Toripalimab in Patients with Bulky Solid Tumors Refractory to Standard Therapy (China)

Posted On: 2026-09-10

China, Sept. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Study of Central Radiofrequency Ablation (SCART) Combined with Toripalimab in Patients with Bulky Solid Tumors Refractory to Standard Therapy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132034

Registration Time: 2026/09/09

Type: Interventional study

Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342207

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Clinical Study of Central Radiofrequency Ablation (SCART) Combined with Toripalimab in Patients with Bulky Solid Tumors Refractory to Standard Therapy (China)